Purchase Order 140G0126P0291

The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $10,544.00 firm fixed-price purchase order to Qiagen, LLC for combined preventative maintenance agreements on QIACUBE CONNECT and QIAGILITY equipment. The period of performance is from the award date of April 14, 2024 through April 25, 2025. Qiagen, LLC is a division of Qiagen N.V., an international provider of sample and assay technologies that has supported federal agencies' biomedical research,...

<p>The National Institutes of Health Clinical Center awarded a purchase order to Qiagen, LLC for the QiaCube Connect System and accessories, valued at $30,022.00, on June 18, 2020. Performance is located in Germantown, Maryland. The order carries firm fixed price terms and is scheduled for completion by September 30, 2020. The awardee is a foreign-owned manufacturer specializing in molecular diagnostics, scientific equipment, and bioinformatics solutions.</p>

The National Institute of Allergy and Infectious Diseases awarded a purchase order to Qiagen, LLC for $13,936.20 in QIAcube-compatible QIAseq sequencing kits on September 13, 2021, with ultimate completion on July 7, 2022. The order was issued to de-obligate unexpiring fiscal year 2021 funds in accordance with 31 U.S.C. Section 1552(a) ahead of the September 30, 2026 period-of-availability close. Performance takes place in Germantown, Maryland. The purchase order carries firm fixed price pricing...

<p>The National Cancer Institute awarded a purchase order to Qiagen, LLC for $5,992.00 on June 21, 2018, for QIAcube equipment under firm fixed price terms. Performance occurred at Bethesda, Maryland with a period running from June 24, 2018 to June 23, 2019. No set-aside applied.</p>

The U.S. government awarded a $7,748 firm fixed-price purchase order to Qiagen, LLC for inspections and service agreement support related to QIAcube instruments (models 11617 and 11623). The contract, awarded on March 20, 2015, with an ultimate completion date of September 3, 2020, will be performed in Valencia, California. The funding agency is identified as the Plains Area civilian entity. This award was made without set-aside designation, reflecting the contractor's ability to compete in...

This is a firm-fixed-price purchase order contract awarded by the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services, to Qiagen, LLC for a service agreement to maintain Qiagen's QIAcube instruments. The contract has a ceiling value of $24,973.08 and a period of performance through November 30, 2025. Qiagen is an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academics, and has...

The NIH Clinical Center awarded a purchase order to Qiagen, LLC on June 13, 2018, with a ceiling value of $216,766.82 for firm fixed-price delivery of QIAGEN products and services. The order's ultimate completion date was December 31, 2020. Place of performance is Valencia, California. This purchase order is now being administratively de-obligated to close unexpended fiscal year 2021 funding in preparation for the September 30, 2026 period-of-availability closing, in accordance with 31 U.S.C....

<p>The National Institute of Mental Health awarded a purchase order to Qiagen, LLC for a QIAcube Connect automated nucleic acid extraction instrument valued at $30,875.78 on August 3, 2026, with ultimate completion on August 2, 2027. Place of performance is Bethesda, Maryland. The order is firm fixed price with no small business set-aside.</p>

<p>The NIH Clinical Center issued a purchase order to Qiagen, LLC on June 12, 2018 for $7,808.68 with firm fixed-price pricing and an ultimate completion date of June 20, 2018. Performance is at Bethesda, Maryland. The source does not specify what is being purchased.</p>

<p>The National Institutes of Health Clinical Center issued a purchase order to Qiagen, LLC on August 4, 2017, for $12,830.65 under firm fixed price terms, with performance completion by August 10, 2017. Work is performed at Bethesda, Maryland. The order procures molecular diagnostics products and supplies, which are part of Qiagen's standard federal portfolio of DNA/RNA extraction kits, reagents, and laboratory consumables supporting biomedical research and clinical diagnostic operations.</p>